Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 47,083 | 43,766 | 72,178 | 56,116 | 54,568 |
| Cost of Goods | 10,658 | 10,728 | 24,323 | 13,284 | 11,857 |
| Gross Profit | 36,425 | 33,038 | 47,855 | 42,832 | 42,711 |
| Operating Expenses | 39,262 | 36,065 | 33,380 | 34,531 | 38,676 |
| Operating Income | -2,179 | -2,299 | 14,798 | 8,585 | 4,892 |
| Interest Expense | 3,372 | 3,359 | 3,354 | 3,339 | 3,325 |
| Other Income | 1,400 | 1,063 | 1,360 | 763 | 746 |
| Pre-tax Income | -4,151 | -4,595 | 12,804 | 6,009 | 2,313 |
| Income Tax | 378 | 220 | 536 | 213 | 187 |
| Net Income Continuous | -4,529 | -4,815 | 12,268 | 5,796 | 2,126 |
| Net Income | $-4,529 | $-4,815 | $12,268 | $5,796 | $2,126 |
| EPS Basic Total Ops | -0.09 | -0.10 | 0.26 | 0.12 | 0.05 |
| EPS Basic Continuous Ops | -0.09 | -0.10 | 0.26 | 0.12 | 0.05 |
| EPS Diluted Total Ops | -0.09 | -0.10 | 0.25 | 0.12 | 0.05 |
| EPS Diluted Continuous Ops | -0.09 | -0.10 | 0.26 | 0.12 | 0.05 |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.10 | 0.26 | N/A | N/A |
| EBITDA(a) | $729 | $598 | $17,687 | $11,461 | $7,768 |